检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:朱瑞洁 吴安 牧启田[3] 欧阳桂芳 ZHU Ruijie;WU An;MU Qitian;OUYANG Guifang(Zhejiang University School of Medicine,Hangzhou 310029,China;不详)
机构地区:[1]浙江大学医学院,浙江杭州310029 [2]浙江大学宁波医院 [3]宁波大学附属第一医院
出 处:《中国医学创新》2023年第20期141-145,共5页Medical Innovation of China
基 金:浙江省自然科学基金(LY20H080001);浙江省医药卫生科技计划项目(2021KY273)。
摘 要:目的:探讨初诊骨髓增生异常综合征(MDS)患者血小板动态变化与其预后的关系。方法:本研究收集了2009年1月—2021年12月于宁波大学附属第一医院就诊的200例MDS患者的临床资料,将半年内血小板计数(PLT)下降超过50%的患者定义为研究组(n=113),未超过50%的定义为对照组(n=87),通过分析对照组与研究组的临床实验室资料及生存情况,研究两组患者的临床特征和预后差异。结果:研究组初诊时血小板计数低于对照组,骨髓原始细胞比例高于对照组,IPSS-R分期高危与极高危组人数的比例高于对照组,总生存期及无白血病生存期显著低于对照组,并有更高的转白率,差异均有统计学意义(P<0.05)。结论:半年内血小板下降≥50%的MDS患者初诊时血小板计数更低,骨髓原始细胞比例更高,且具有更差的预后。Objective:To investigate the relationship between platelet dynamic changes and prognosis in newly diagnosed MDS patients.Method:This study collected the clinical data of 200 MDS patients in the First Affiliated Hospital of Ningbo University from January 2009 to December 2021.The patients whose PLT decreased by more than 50%within half a year were selected as the study group(n=113),and those whose PLT decreased by less than 50%were defined as the control group(n=87).By analyzing the clinical laboratory data and survival conditions of the control group and the study group,the differences in clinical features and prognosis were studied between the two groups.Result:The platelet count of patients in the study group was lower than that in the control group at initial diagnosis,the proportion of bone marrow primitive cells was higher than that in the control group,the proportion of patients in the high-risk and extremely high-risk IPSS-R stage group was higher than that in the control group,the overall survival time and leukemia-free survival time of patients in the study group were significantly lower than the control group,and there was a higher rate of leukemic transformation,the differences were statistically significant(P<0.05).Conclusion:MDS patients with≥50%platelet decline within six months has lower platelet counts,and higher proportion of bone marrow primitive cells at first diagnosis,and a poorer prognosis.
分 类 号:R551.3[医药卫生—血液循环系统疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28